Monoclonal antibody drugs

Slides:



Advertisements
Similar presentations
Dr.Mohammed Sharique Ahmed Quadri Assistant professor Physiology
Advertisements

Applications of Biotechnological Processes Antibody Production.
Topics 6&11 Defence against infectious disease cont’d.
Understanding the Immune System
Monoclonal Antibodies. Antibodies have important uses beyond fighting infections in the body. Production of long-lasting monoclonal antibodies is a recent.
Hybridoma Technique.
Biopharmaceutical Products Touqeer Ahmed Ph.D. Atta-ur-Rahman School of Applied Bioscience, National University of Sciences and Technology 23 rd September,
Immunity 6.5 Antibodies.
Chapter 18 Autoimmune Diseases 1. 1.Immunological homeostasis: To self Ag, our immune system is in tolerance and immune response won’t take place. Immune.
Production of Monoclonal antibodies
Chapter 4: Serology Concepts. What is an antigen?  An antigen is any substance that elicits an immune response and is then capable of binding to the.
“MONOCLONAL ANTIBODIES” Jony Mallik M
Use of Monoclonal Antibodies Against Autoimmune Diseases By: Kelly Sambuchi ISAT 351 Spring 1999.
Monoclonal antibodies Hybridoma Technique. Monoclonal antibodies (mAb or moAb) Monoclonal antibodies are:  monospecific antibodies that are identical.
By Matthew Sampson. Overview What is it? Previous Treatments Monoclonal Antibodies Chimeric Molecules Oral Therapies Hematopoietic Stem Cells Future.
Monocolonial Antibody. IB Learning Objective Describe the production of monoclonal antibodies.
MONOCLONAL ANTIBODIES
Lec 16 Medical biotechnology Shah Rukh Abbas, PhD
White blood cells & the immune system What does it mean to be immune to something? Leucocyte (WBC) Phagocytes (engulf & destroy) = Inflammation Lymphocytes.
ABDUALLAH SAUD AL-SHETELY
Chapter 11 Practical Applications of Immunology. Vaccine History Variolation: Inoculation of smallpox into skin (18th century). Vaccination: Inoculation.
18-1 Important terms: Hypersensitivity – immune responses that causes tissue damage Autoimmune disease – immune responses to self-antigens Immunodeficiency.
Adaptive Immunity: Specific Defenses of the host
Monoclonal Antibodies Aims: Must be able to define the term monoclonal antibody. Should be able to outline the possible uses of monoclonal antibodies.
Recombinant DNA in Medicine Industry- Monoclonal Antibodies Topics in Nanobiotechnology- April Maria Viviana Duarte.
Kara Kliethermes Jim Shinaberry December 6, 2012.
BCM 410A lecture 35 immunity immunoglobulin structure antibody classes monoclonal antibodies immunity immunoglobulin structure antibody classes monoclonal.
APPLICATIONS OF MONOCLONAL ANTIBODIES
Gene Therapy. Gene Therapy is a technique for correcting defective genes responsible for disease development Gene Therapy is a technique for correcting.
IMMUNE SYSTEM OVERVIEW
( Slow Acting Anti-inflammatory Drugs ). OBJECTIVES At the end of the lecture the students should Define DMARDs Describe the classification of this group.
Autoimmunity: Autoimmunity : the immune response which directed against host tissue self epitopes due to loss of tolerance. Self-Tolerance: The non-responsiveness.
White blood cells and their disorders Dr K Hampton Haematologist Royal Hallamshire Hospital.
Ch. 11 Part 4-Autoimuune Disease and Monoclonal Antibodies.
Advances in the Treatment of Crohn’s Disease GASTROENTEROLOGY 2004;126:1574–1581.
KSU Microbiology section Dr. sarah I bukhari Assistant Professor of pharmaceutical microbiology.
Immunotherapy. Definition The approach to balance or intervene the immunologic function in order to fight against the disease by the principle of immunology.
Pharmaceutical Biotechnology
DIAGNOSIS OF DISEASES AND GENE THERAPY
Chapter 43 The Immune System.
B-cell mediated disease
Cancer and the Immune System
Immune Keytruda.
R1.이용석 / modulator pf.한재준.
Pharmaceutical Biotechnology
MONOCLONAL ANTIBODIES
MONOCLONAL ANTIBODIES
CHAPTER 24 The Immune System
Autoimmune Diseases Autoimmune Diseases Presented By Dr. Manal Yassin.
Globular Protein Made of amino acid chains
Pharmaceutical Biotechnology
Transplantation David Straus, Ph.D. Objectives
Tissue and Organ Transplantation
chimeric antigen receptor T-cell therapy for ALL
Introduction to the Biotechnology Workplace
Introduction to the Biotechnology Workplace
Immunological Pregnancy Testing
Monoclonal Antibodies
Monoclonal Antibodies
Immunological Tolerance
HEREDITY S.W.B.A.T. EVALUATE THE IMPORTANCE OF ADVANCES IN GENETICS
Recombinant Vaccines A recombinant vaccine is a vaccine produced through recombinant DNA technology. This involves inserting the DNA encoding an antigen.
Immunological Technique
Biological Therapies for Inflammatory Bowel Diseases
ADVANCES IN REPRODUCTIVE TECHNOLOGY
Exam Three, packet 4 Antigen Recognition
Gene Therapy (Zinc-finger nuclease, Crisper-CAS 9)
HYBRIDOMA TECHNOLOGY & PRODUCTION OF MONOCLONAL ANTIBODIES
Lec 6 Monoclonal Antibody.
Presentation transcript:

Monoclonal antibody drugs Pharmaceutical chemistry Monoclonal antibody drugs Assist . Prof . Karima F. Ali Al-mustansiriyah university college of pharmacy

Monoclonal Antibodies Monoclonal antibodies (mAb or moAb) are monospecific antibodies that are made by identical immune cells that are all clones of a unique parent cell, in contrast to polyclonal antibodies which are made from several different immune cells. Monoclonal antibodies have monovalent affinity, in that they bind to the same epitope

Therapeutic treatment Therapeutic monoclonal antibodies describe one example of plant derived anticancer compound and explain its mechanism of action. Act through a number of mechanisms, such as blocking of targeted molecule functions, inducing apoptosis of cells which express the target, or by modulating signalling pathways Cancer treatment: One possible treatment for cancer involves monoclonal antibodies that bind only to cancer cell- specific antigens and induce an immunological response against the target cancer cell.

Autoimmune Diseases: Monoclonal antibodies used for autoimmune diseases include: a. infliximab and adalimumab, which are effective in rheumatoid arthritis, Crohn's disease, ulcerative Colitis and ankylosing spondylitis by their ability to bind to and inhibit TNF-α b. Basiliximab and daclizumab inhibit IL-2 on activated T cells and thereby help prevent acute rejection of kidney transplants c. Omalizumab inhibits human immunoglobulin E (IgE) and is useful in moderate-to-severe allergic asthma.

Monoclonal antibodies are typically made by fusing myeloma cells with the spleen cells from a mouse that has been immunized with the desired antigen. However, recent advances have allowed the use of rabbit B-cells to form a rabbit hybridoma. Polyethylene glycol is used to fuse adjacent plasma membranes, but the success rate is low so a selective medium in which only fused cells can grow is used.

The selective culture medium is called HAT medium because it contains hypoxanthine, aminopterin, and thymidine. This medium is selective for fused (hybridoma) cells.

Monoclonal Antibody Drugs: Rituximab: (Rituxan, Chimeric) is an Mab directed against the CD20 antigen expressed on the surfaces of normal and malignant B lymphocytes. Rituximab is indicated for the treatment of patients with relapsed or refractory, low-grade or follicular, CD20 B-cell non-Hodgkin lymphoma. CD20 is a protein of 35 to 37 k Da, and it may play a role in B cell activation and regulation and may be a calcium ion channel.

Alemtuzumab: (Campath) is humanized MAb (Campath-1H) that is directed against the 21- to 28-k Da cell surface glycoprotein CD 52. CD 52 is expressed on the surface of normal and malignant B and T lymphocytes, monocytes, macrophages, and tissues of the male reproductive system. Alemtuzumab is indicated for the treatment of B-cell chronic lymphocytic leukemia in patients who have been treated with alkylating agents and who have failed on this therapy.

Monoclonal Antibody RadionuclideTest Kits A rcitumomab, nofetumomab merpentan , satumomab pendetide, imciromab pentetate Nofetumomab merpentan (Verluma Kit) is the Fab fragment derived from the murine MAb NR-LU-10. The product is a protein, IgG2b, monoclonal that has been fragmented from NR- LU-10. Nofetumomab possesses only the Fab portion. NR-LU-10 and nofetumomab are directed against a 40-kDa protein antigen that is expressed in various cancers and some normal tissues..

Nofetumomab is indicated for the detection and evaluation of extensive-stage disease in patients with biopsy-confirmed, previously untreated small cell lung cancer by bone scan, CT scan (head, chest, abdomen), or chest x-ray. Nofetumomab merpentan possesses a linker and a chelator that binds the technetium to the peptide. This is a phenthioate ligand, 2,3,5,6tetrafluorophenyl-4,5-bis-S-[1 ethoxyethyl] - thioacetoamidopentanoate, hence the name merpentan

In-Home Test Kits There are various MAb-based in-home test kits that are designed to detect pregnancy and ovulation. For example, a pregnancy test kit targets the antigen human chorionic gonadotropin and displays a certain sign if the test is positive. The other type of test kit predicts ovulation by targeting LH in the urine. Just before ovulation, LH surges. The test kit is designed to detect and signal the time of ovulation. These test kits, based on the complex techniques of MAbs, are designed to be as simple and error- free as possible for patients.

Gene Therapy Gene therapy arguably represents the ultimate application of rDNA (Recombinant DNA) technology to the treatment of disease. There are two ways to envision gene therapy: (a) the replacement of a defective gene with a normal gene (b) the addition of a gene whose product can help fight a disease such as a viral infection or cancer. In the former case, replacement of a defective gene, an actual cure can be effected instead of just treating the symptoms.

Similar possibilities exist for other inherited It is possible that replacement of the defective gene with a corrected one could produce a cure. Similar possibilities exist for other inherited genetic disorders such as insulin-dependent diabetes, growth hormone deficiency, hemophilia, and sickle cell anemia. The ability to transfer genes into other organisms has other important applications, including the heterologous production of recombinant proteins and the development of animal models for the study of human diseases.

Another area of exploration is the introduction of recombinant genes as biological response modifiers, for example, in preventing rejection following organ transplantation. An opposite strategy might be considered for the treatment of cancer, whereby transplanted cells could be used to target cancer cells, increasing local cell- mediated immune responses.